Magow Rajesh sold 20,000 shares of MakeMyTrip Ltd at $45.25 for −$905k on Nov 3, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Group Chief Executive Officer
Group Chief Executive Officer
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$905,000Shares × reported price
Shares traded
20,000Ordinary Shares
Price per share
$45.25Reported price. Read footnotes for ranges.
% of reported position traded
100%This security and ownership context
Holdings after
0Direct
Trade date
Nov 3, 2026Sell
Filed
Nov 5, 2026, 9:35 AM ET2-day reporting delay
Accession
0001193125-26-448845Code S · Transaction 393194
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 20,000 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 3, 2026Option exercise20,000$0.00$10Trade 393193
Nov 4, 2026Option exercise10,000$0.00$5Trade 393195
Nov 3, 2026Option exercise20,000$0.00$0Trade 393197
Nov 4, 2026Option exercise10,000$0.00$0Trade 393198
Nov 4, 2026Sell10,000$50.11−$501,100Trade 393196
6 transaction rows in this filing. Joint filers share the same rows.

MMYT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MMYT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +3.1%30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $45.20 to $45.45. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote. F2: The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $50.01 to $50.37. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote. F3: Following the transaction dated November 3, 2026, 1,384,185 Restricted Stock Units (RSUs) are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 ordinary shares subject to the achievement of certain performance-based vesting conditions. F4: Following the transaction dated November 4, 2026, 1,374,185 RSUs are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions.